Nuvo Research Announces 2012 Third Quarter Results

Published November 1, 2012

Nuvo Research announces 2012 third quarter results

Filed under: drug treatment news 2012

MISSISSAUGA, ON, Oct. 31, 2012 — /PRNewswire/ – Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug …
Read more on Sacramento Bee

PropThink: Sizing Up Elagolix – A Blockbuster Drug

Filed under: drug treatment news 2012

In June 2012, Abbott Labs (NYSE:ABT) initiated a phase III clinical trial with elagolix to evaluate the safety and efficacy of the drug in female patients with endometriosis. Below we …. Importantly, there were no elagolix treatment-related serious …
Read more on Reuters